Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
  Proliferation-Associated Ki-67 Protein Is a Target for Autoantibodies in the Human Autoimmune Disease Systemic Lupus Erythematosus
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  Christiane Gerlach, Michael Kubbutat, Ulrich Schwab, Goran Key, Hans-D. Flad, and Johannes Gerdes
   
  Second Department of Pathology, Kanazawa University School of Medicine, Kanazawa, Japan
   
  The monoclonal antibody Ki-67, originally described by Gerdes et al in 1983, selectively reacts with nuclei of proliferating cells in human tissues. Detailed cell cycle analysis has shown that this nuclear protein, designated as Ki-67 protein, is exclusively expressed during the cell division cycle in the G1, S, and G2 phases as well as in mitosis and that it is absent in the G0 phase (Gerdes et al, 1984). Because of this property, the monoclonal antibody Ki-67 has become a useful tool for estimating the growth fraction in malignant disease. Recently, Bloch et al (1995) reported that the Ki-67 protein is a target of murine autoantibodies. In sera from MRL/MpJ-+/+ and MRL/MpJ-lpr/lpr mice, they detected autoantibodies with reactivity against a recombinant peptide of the human Ki-67 protein. The MRL mouse strain shows features that are closely related to the clinical syndrome of the autoimmune disease systemic lupus erythematosus (SLE; Theofilopoulos and Dixon, 1985). Thus, Bloch et al (1995) suggested that the detection of Ki-67 protein-specific autoantibodies in the MRL mouse strain and further characterization of this phenomenon may give clues to the etiology and pathogenesis of autoimmune disease in these animals. The present study demonstrates that sera from several SLE patients contained autoantibodies against the Ki-67 protein, indicating that this cell proliferation-associated protein is present as an autoantigen under the pathogenic conditions that result in SLE.

An immunoprecipitation method was established that allowed the enrichment of the Ki-67 protein from proliferating cells and the electrophoretic-based demonstration of both polypeptides constituting the Ki-67 protein (Schluter et al, 1993). Figure 1 shows a silver-stained SDS-PAGE from a sequential immunoprecipitation experiment. In the first step, the Ki-67 polypeptides were precipitated from a lysate of IM-9 cells with the monoclonal antibody MIB-21, which is specific for the carboxyterminus of the Ki-67 protein. The resultant immunoprecipitates were further purified by a second immunoprecipitation step using the monoclonal antibody MIB-24, which recognizes the aminoterminus. The apparent molecular weight was calculated by computer-aided analysis of several silver-stained SDS-PAGEs, yielding an average apparent molecular weight of 350 kd for the longer polypeptide and 315 kd for the smaller form of the Ki-67 protein isoform. This finding indicates that our previously published molecular weights, as determined using IM-9 lysates instead of immunoprecipitates, were slightly overestimated (Schluter et al, 1993).

Figure 2 shows the results obtained from the modified immunoprecipitation protocol mentioned above. A single immunoprecipitation step with the monoclonal antibody MIB-1, which was found to be equivalent to the prototype antibody Ki-67, was performed, and immunoprecipitates were immobilized onto nitrocellulose filter by Western blotting (Key et al, 1993). Sera from 20 healthy blood donors and from 18 patients suffering from SLE were analyzed for reactivity against the MIB-1 immunoprecipitates. Whereas the sera of 19 blood donors were negative by immunoblot analysis, the presence of autoantibodies could not be excluded in one control serum (data not shown). In contrast, immunoblot analysis showed that 6 of 18 sera samples reacted with the Ki-67 protein isoforms, indicating that these patients had developed antibodies against this cell proliferation-associated nuclear protein. In our series, we found a preferential reactivity with the small type of the Ki-67 protein in two of six positive sera. Furthermore, some sera showed strong reactions to proteins of lower molecular weight, which represented either fragments of the Ki-67 protein or different proteins coprecipitated with the monoclonal antibody MIB-1. The precise characterization of these proteins is currently underway.

In summary, not only are there Ki-67 protein-specific antibodies in the sera from MRL mice, but autoantibodies with specificity against both Ki-67 protein isoforms could also be found in sera from SLE patients. These findings provide further evidence that an immune response directed against the Ki-67 protein may be a common phenomenon in SLE and related diseases. Further investigations should be able to clarify whether there is a relationship between the pathogenesis and/or severity of this disease and the production of autoantibodies specific for the cell division cycle-associated Ki-67 protein.

Acknowledgements  

We thank R. Da[beta]ler and B. Baron for excellent technical assistance.  

References  

Bloch DB, Rabkina D, and Bloch KD (1995). The cell proliferation-associated protein Ki-67 is a target of autoantibodies in the serum of MRL mice. Lab Invest 73:366-371.  

Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, and Stein H (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715.  

Gerdes J, Schwab U, Lemke H, and Stein H (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20.  

Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad HD, and Gerdes J (1993). New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 66 Bp repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629-635.  

Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.  

Leary JJ, Brigati DJ, and Ward DC (1983). Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitro-cellulose: Bio-blots. Proc Natl Acad Sci USA 80:4045-4049.  

Muro Y, Kano T, Sugiura K, and Hagiwara M (1997). Low frequency of autoantibodies against Ki-67 antigen in Japanese patients with systemic autoimmune diseases. J Autoimmunity 10:499-503.  

Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad HD, and Gerdes J (1993). The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123:513-522.  

Theofilopoulos AN and Dixon F (1985). Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390.  

Towbin H, Staehelin T, and Gordon J (1979). Electrophoretical transfer of proteins from polyacrylamide gels to nitro-cellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.  

Received September 24, 1997.  

Affiliations: Department of Neurosurgery (CG), Medical University of Lubeck, Lubeck, Germany; National Cancer Institute (MK), Frederick, Maryland; Medizinische- und Poliklinik der Christian-Albrechts-Universitat im Stadtischen Krankenhaus Kiel (US), Kiel, Germany; Department of Immunology and Cell Biology (HDF, JG), Forschungszentrum Borstel, Borstel, Germany; and Institut fur Chemo- und Biosensorik, Division of Immunotechnology (GK), Munster, Germany.  

Note added in proof: After we submitted the present contribution, Muro et al (1997) reported similar observations in the October issue of the Journal of Autoimmunity.  

The study was supported in part by the Dr. Mildred Scheel Stiftung fur Krebsforschung Project W23/93/G3.  

Address reprint requests to: Dr. J. Gerdes, Department of Immunology and Cell Biology, Forschungszentrum Borstel, Parkallee 22, 23845 Borstel, Germany. Fax: 49 4537 188 724